4.5 Article

Next-generation re-sequencing of genes involved in increased platelet reactivity in diabetic patients on acetylsalicylic acid

Journal

PLATELETS
Volume 27, Issue 4, Pages 357-364

Publisher

TAYLOR & FRANCIS INC
DOI: 10.3109/09537104.2015.1109071

Keywords

Acetylsalicylic acid; diabetes mellitus; genetic polymorphism; next-generation sequencing; platelet reactivity

Funding

  1. Fulbright Fellowship
  2. Polish Pharmaceutical Company ADAMED [1WR DAR1/2007]

Ask authors/readers for more resources

The objective of this study was to investigate whether rare missense genetic variants in several genes related to platelet functions and acetylsalicylic acid (ASA) response are associated with the platelet reactivity in patients with diabetes type 2 (T2D) on ASA therapy. Fifty eight exons and corresponding introns of eight selected genes, including PTGS1, PTGS2, TXBAS1, PTGIS, ADRA2A, ADRA2B, TXBA2R, and P2RY1 were re-sequenced in 230 DNA samples from T2D patients by using a pooled PCR amplification and next-generation sequencing by Illumina HiSeq2000. The observed non-synonymous variants were confirmed by individual genotyping of 384 DNA samples comprising of the individuals from the original discovery pools and additional verification cohort of 154 ASA-treated T2DM patients. The association between investigated phenotypes (ASA induced changes in platelets reactivity by PFA-100, VerifyNow and serum thromboxane B2 level [sTxB2]), and accumulation of rare missense variants (genetic burden) in investigated genes was tested using statistical collapsing tests. We identified a total of 35 exonic variants, including 3 common missense variants, 15 rare missense variants, and 17 synonymous variants in 8 investigated genes. The rare missense variants exhibited statistically significant difference in the accumulation pattern between a group of patients with increased and normal platelet reactivity based on PFA-100 assay. Our study suggests that genetic burden of the rare functional variants in eight genes may contribute to differences in the platelet reactivity measured with the PFA-100 assay in the T2DM patients treated with ASA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Actual status and future directions of cardiac telerehabilitation

Krzysztof Milewski, Pawel Balsam, Mateusz Kachel, Bronislaw Sitek, Aleksandra Kolarczyk-Haczyk, Szymon Skoczynski, Piotr Hirnle, Monika Gawalko, Lukasz Koltowski, Renata Glowczynska, Tomasz Zajac, Andrzej Malecki, Agata Nowak, Pawel Kazmierczak, Ewa Piotrowicz, Ryszard Piotrowicz, Milosz Jaguszewski, Grzegorz Opolski, Marcin Grabowski

Summary: Telerehabilitation (TR) was developed to overcome geographical barriers and staff deficiencies in delivering rehabilitation services, especially during crisis situations like the COVID-19 pandemic. It has been shown to have similar clinical outcomes and cost-effectiveness compared to traditional rehabilitation, but also has limitations such as lack of direct contact and patient competencies in handling mobile devices. This article discusses the current status of TR, with a focus on cardiac rehabilitation, covering technical/organizational and legal aspects, indications, cost-effectiveness, and future directions.

CARDIOLOGY JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Third-Generation Sirolimus-Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes-a FANTOM STEMI Pilot Study

Lukasz Koltowski, Mariusz Tomaniak, Dorota Ochijewicz, Grzegorz Opolski, Janusz Kochman

Summary: The purpose of this study was to assess the safety and effectiveness of the Fantom BRS 6 months after implantation using optical coherence tomography (OCT) imaging. The results showed that there were no major adverse cardiac events or device-orientated composite endpoints within the 6-month follow-up period. Furthermore, quantitative coronary angiography (QCA) and OCT imaging revealed a decrease in lumen diameter and area, as well as improved expansion index and malposition rate.

CARDIOVASCULAR DRUGS AND THERAPY (2023)

Article Neurosciences

Long-term Administration of 3-Di-O-Tolylguanidine Modulates Spatial Learning and Memory in Rats and Causes Transition in the Concentration of Neurotransmitters in the Hippocampus, Prefrontal Cortex and Striatum

Agnieszka Piechal, Alicja Jakimiuk, Justyna Pyrzanowska, Kamilla Blecharz-Klin, Ilona Joniec-Maciejak, Alicja Wiercinska-Drapalo, Dagmara Mirowska-Guzel, Ewa Widy-Tyszkiewicz

Summary: sigma-1 and sigma-2 receptors are highly concentrated in the brain and their altered expression can lead to neuropsychiatric disorders. Administering DTG to rats affected their learning and memory processes as well as neurotransmitter levels in selected brain structures. The administration of DTG showed dose-dependent effects on memory, with the DTG10 group showing improvement while the DTG30 group performed worse.

NEUROSCIENCE (2023)

Article Physiology

An assessment of heart rate and blood pressure asymmetry in the diagnosis of vasovagal syncope in females

Rafal Pawlowski, Pawel Zalewski, Julia Newton, Agnieszka Piatkowska, Edward Kozluk, Grzegorz Opolski, Katarzyna Buszko

Summary: Heart Rate Asymmetry (HRA) refers to the differences between accelerations and decelerations in human heart rate. The methods used for HRA assessment can also be applied to evaluate asymmetry in blood pressure variations (BPA). Through the analysis of heart rate and blood pressure signals from vasovagal patients and healthy individuals, it was found that HRA indicators changed only in the control group during tilt stage. Additionally, the vasovagal patients had significantly different pulse pressures compared to the healthy subjects.

FRONTIERS IN PHYSIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry

Monika Budnik, Monika Gawalko, Piotr Lodzinski, Agata Tyminska, Krzysztof Ozieranski, Marcin Grabowski, Michal Peller, Anna Wancerz, Marek Kiliszek, Grzegorz Opolski, Radoslaw Lenarczyk, Zbigniew Kalarus, Gregory Y. H. Lip, Pawel Balsam

Summary: Heart failure has a significant impact on clinical outcomes in atrial fibrillation patients, leading to higher mortality rates and more frequent cardiovascular interventions and events. There is no statistically significant difference in long-term outcomes among different types of heart failure.

ESC HEART FAILURE (2023)

Article Clinical Neurology

Serum levels of matrix metalloproteinase 2 and its inhibitor after tonic-clonic seizures

A. Cudna, E. Bronisz, D. Mirowska-Guzel, I. Kurkowska-Jastrz Ebska

Summary: Damage to the blood-brain barrier (BBB) from neuroinflammation after epileptic seizures can disrupt brain homeostasis. This study examined the involvement of modulatory proteins in BBB integration. Serum analysis of 50 epilepsy patients showed slight increases in MMP-2 levels after seizures, along with decreases in TSP-1 and -2 levels and an increase in TIMP-2 expression. However, there were no significant changes in alpha 2-macroglobulin and MMP-7 levels. These findings suggest the initiation of repair processes and improved integrity of the BBB after seizures. Further studies correlating serum markers with brain expression are needed for potential identification of epileptic seizure biomarkers.

EPILEPSY RESEARCH (2023)

Article Clinical Neurology

Olfactory dysfunction in patients with Wilson?s Disease

Agnieszka Piechal, Jan Bembenek, Anna Baranowska, Tomasz Litwin, Dagmara Mirowska-Guzel, Anna Czlonkowska

Summary: This study evaluated olfactory dysfunction in patients with Wilson's Disease (WD) and found that patients with WD had a weaker sense of smell compared to healthy controls. Older individuals and those with predominantly neurological symptoms were more likely to experience olfactory disorders.

NEUROLOGIA I NEUROCHIRURGIA POLSKA (2023)

Article Medicine, General & Internal

Circulating Extracellular Vesicle Levels in Patients with Coronavirus Disease 2019 Coagulopathy: A Prospective Cohort Study

Yudai Iwasaki, Yusuke Takei, Mitsuhiro Yamada, Shigekazu Sugino, Koji Saito, Tetsuji Aoyagi, Kengo Oshima, Hajime Kanamori, Hiroaki Baba, Kentarou Takei, Koichi Tokuda, Eichi N. Kodama, Tetsuro Kamo, Tadashi Kamio, Takehiko Kasai, Satoru Ogawa, Masanori Yamauchi

Summary: This study aimed to evaluate the association between COVID-19 coagulopathy and extracellular vesicle (EV) levels. No significant difference was found in EV levels between COVID-19 coagulopathy patients and non-coagulopathy patients. However, CD41+ EV levels were significantly higher in COVID-19 coagulopathy patients and might play an essential role in the development of COVID-19 coagulopathy.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Mobile App and Digital System for Patients after Myocardial Infarction (afterAMI): Results from a Randomized Trial

Bartosz Krzowski, Maria Boszko, Michal Peller, Paulina Hoffman, Natalia Zurawska, Kamila Skoczylas, Gabriela Osak, Lukasz Koltowski, Marcin Grabowski, Grzegorz Opolski, Pawel Balsam

Summary: Cardiac rehabilitation after acute myocardial infarction is crucial for improving patients' prognosis. This study aimed to evaluate a mobile application for post-heart attack patients and investigate the impact of a digitally-supported model of care compared to standard rehabilitation. Although the study did not show a significant reduction in rehospitalizations, patients using the mobile app had lower levels of NT-proBNP and better knowledge of cardiovascular disease risk factors. This study demonstrates the potential of telemedical tools in the clinical setting.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Clinical Neurology

Fingolimod Modulates the Gene Expression of Proteins Engaged in Inflammation and Amyloid-Beta Metabolism and Improves Exploratory and Anxiety-Like Behavior in Obese Mice

P. L. Wencel, K. Blecharz-Klin, A. Piechal, J. Pyrzanowska, D. Mirowska-Guzel, R. P. Strosznajder

Summary: Obesity is a risk factor for type 2 diabetes and is related to memory and executive function decline. Fingolimod, an S1PR modulator, can improve gene expression in the brains of obese mice and restore normal cognitive behavior patterns, suggesting a beneficial effect on CNS function.

NEUROTHERAPEUTICS (2023)

Review Pharmacology & Pharmacy

Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies

Alicja Jakimiuk, Agnieszka Piechal, Alicja Wiercinska-Drapalo, Alicja Nowaczyk, Dagmara Mirowska-Guzel

Summary: Evaluation of dolutegravir reveals a risk of CNS disorders associated with long-term use. Pharmacokinetics and clinical trials assessing adverse effects and discontinuation frequency were reviewed. Factors affecting CNS disorders were summarized, highlighting the importance of pharmacovigilance for newly registered drugs.

PHARMACOLOGICAL REPORTS (2023)

Article Cardiac & Cardiovascular Systems

Heart team consultations for patients with severe coronary artery disease or valvular heart disease in the era of the COVID-19 pandemic: a single-center experience

Szymon Jonik, Maria Boszko, Elena Sztemberg, Dominik Lepecki, Bartlomiej Grodzinski, Marcin Mikusek-Pham Van, Michal Marchel, Janusz Kochman, Mariusz Kusmierczyk, Grzegorz Opolski, Marcin Grabowski, Tomasz Mazurek

Summary: This study investigates the impact of the COVID-19 pandemic on the functioning of the Heart Team. The results show a decrease in the number of meetings and consulted patients, as well as changes in treatment strategies, suggesting a significant impact of the pandemic on the Heart Team.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Article Biochemistry & Molecular Biology

Inflammatory Forms of Cardiomyocyte Cell Death in the Rat Model of Isoprenaline-Induced Takotsubo Syndrome

Sonia Borodzicz-Jazdzyk, Agnieszka Kolodzinska, Katarzyna Czarzasta, Malgorzata Wojciechowska, Renata Glowczynska, Benedykt Szczepankiewicz, Liana Puchalska, Grzegorz Opolski, Agnieszka Cudnoch-Jedrzejewska

Summary: The aim of this study was to evaluate the presence and dynamics of necroptosis and pyroptosis in the rat model of TTS. The results showed higher plasma concentrations of interleukin-1β in TTS patients compared to controls. Protein expression associated with necroptosis and pyroptosis was observed in the myocardium after the injection of isoprenaline. These findings suggest that TTS is associated with inflammatory-associated programmed cell death and inflammation may occur simultaneously with cardiomyocyte death.

BIOMEDICINES (2023)

Review Cardiac & Cardiovascular Systems

An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis

Michal Wasiak, Mateusz Tajstra, Dariusz Kosior, Mariusz Gasior

Summary: Recent data shows that there is no mortality benefit from implantable cardioverter-defibrillator (ICD) therapy compared to optimal medical treatment in patients with non-ischemic cardiomyopathy. Despite recommendations for ICD implantation remaining unchanged, these findings have significantly impacted the routine practice of ICD implantation in Europe.

CARDIOLOGY JOURNAL (2023)

Review Primary Health Care

Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice

Dagmara Mirowska-Guzel, Magdalena Niedzielko, Rafal Kulakowski

Summary: Nirmatrelvir/ritonavir (Paxlovid) is indicated for high-risk patients with severe COVID-19, with ritonavir acting as a pharmacokinetic booster. Ritonavir can affect plasma levels of other drugs, potentially leading to interactions and adverse reactions. Data on the clinical impact of Paxlovid DDIs is currently lacking, and there is uncertainty in managing the co-administration of various medications.

FAMILY MEDICINE AND PRIMARY CARE REVIEW (2023)

No Data Available